Healthcare Triangle Enters Material Definitive Agreement
Ticker: HCTI · Form: 8-K · Filed: Nov 19, 2025 · CIK: 1839285
| Field | Detail |
|---|---|
| Company | Healthcare Triangle, Inc. (HCTI) |
| Form Type | 8-K |
| Filed Date | Nov 19, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001, $20,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement
Related Tickers: HTRI
TL;DR
HTRI just signed a big deal, filing 8-K today.
AI Summary
Healthcare Triangle, Inc. announced on November 18, 2025, that it has entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offices in Pleasanton, CA, filed this 8-K report to disclose this significant development.
Why It Matters
This filing indicates a significant business transaction for Healthcare Triangle, Inc., which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities, the specifics of which are not detailed in this initial filing.
Key Players & Entities
- Healthcare Triangle, Inc. (company) — Registrant
- November 18, 2025 (date) — Date of earliest event reported
- Pleasanton, CA (location) — Principal executive offices
- Delaware (location) — State of incorporation
FAQ
What is the nature of the material definitive agreement entered into by Healthcare Triangle, Inc.?
The filing does not specify the nature of the material definitive agreement, only that one has been entered into as of November 18, 2025.
When was the material definitive agreement entered into?
The earliest event reported, which includes the entry into the material definitive agreement, was on November 18, 2025.
What is Healthcare Triangle, Inc.'s principal executive office address?
The principal executive offices are located at 7901 Stoneridge Dr., Suite 220, Pleasanton, CA 94588.
In which state is Healthcare Triangle, Inc. incorporated?
Healthcare Triangle, Inc. is incorporated in Delaware.
What is the SEC file number for Healthcare Triangle, Inc.?
The SEC file number for Healthcare Triangle, Inc. is 001-40903.
Filing Stats: 1,098 words · 4 min read · ~4 pages · Grade level 12.7 · Accepted 2025-11-19 14:27:25
Key Financial Figures
- $0.00001 — ch registered Common Stock, par value $0.00001 per share HCTI The Nasdaq Stock Mar
- $20,000,000 — the Prospectus Supplement is currently $20,000,000. Under the Agreement, the Company wil
Filing Documents
- ea0265944-8k_healthcare.htm (8-K) — 30KB
- ea026594402ex1-1_healthcare.htm (EX-1.1) — 233KB
- ea026594402ex5-1_healthcare.htm (EX-5.1) — 13KB
- ex5-1_001.jpg (GRAPHIC) — 15KB
- 0001213900-25-112546.txt ( ) — 532KB
- hcti-20251118.xsd (EX-101.SCH) — 3KB
- hcti-20251118_lab.xml (EX-101.LAB) — 33KB
- hcti-20251118_pre.xml (EX-101.PRE) — 22KB
- ea0265944-8k_healthcare_htm.xml (XML) — 4KB
01. Entry into a Material Definitive
Item 1.01. Entry into a Material Definitive Agreement. On November 18, 2025, Healthcare Triangle, Inc., a Delaware corporation, (the "Company"), entered into a Sales Agreement (the "Agreement") with Spartan Capital Securities, LLC ("Spartan"), as sales agent providing for the sale by the Company of shares of its common stock, par value $0.00001 per share (the "Common Stock"), from time to time, in an "at the market offering" program through Spartan with certain limitations on the amount of Common Stock that may be offered and sold by the Company as set forth in the Agreement (the "Offering"). The sales, if any, of the shares of Common Stock made under the Agreement will be made by any method permitted by law deemed to be an "at the market offering" as defined in Rule 415 promulgated under the Securities Act of 1933, as amended (the "Securities Act"), including sales made directly on or through the Nasdaq Capital Market or on any other existing trading market for the Common Stock, in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices, and/or in any other method permitted by law. The shares of Common Stock, if any, will be issued pursuant to a prospectus supplement, dated November 18, 2025 (the "Prospectus Supplement"), and an accompanying base prospectus, dated January 31, 2024, contained therein, which together form a part of the Company's "shelf" registration statement on Form S-3 (File No. 333-276382) filed by the Company with the Securities and Exchange Commission ("SEC") on January 5, 2024 and declared effective by the SEC on January 31, 2024. The aggregate market value of the shares of Common Stock eligible for sale under the Prospectus Supplement is currently $20,000,000. Under the Agreement, the Company will set the parameters for the sale of shares, including the number of shares to be sold, the time period during which sales are requested to be made, limitation on the number of
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 1.1 S ales Agreement by and between Healthcare Triangle, Inc. and Spartan Capital Securities, LLC. 5.1 Opinion of Sichenzia Ross Ference Carmel LLP regarding legality of shares of Common Stock 23.1 Consent of Sichenzia Ross Ference Carmel LLP (including in Exhibit 5.1) 104 Cover Page Interactive Data File (embedded within the XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Healthcare Triangle, Inc. Dated: November 19, 2025 By: /s/ David Ayanoglou David Ayanoglou Chief Financial Officer 3